👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

Gap, Ross Stores, Texas Pacific rise premarket; Intuit and Reddit fall

Published 22/11/2024, 13:26
© Reuters.
US500
-
ROST
-
INTU
-
NVDA
-
GAP
-
COP
-
MRO
-
HON
-
MSTR
-
PANW
-
REPL
-
COIN
-

Investing.com -- US stock futures traded in a muted fashion Friday, at the end of a generally positive week.

Here are some of the biggest premarket US stock movers today:

  • Gap (NYSE:GAP) stock rose 18% after the fashion retailer raised its annual sales forecast and said the holiday season was off to a "strong start".

  • Intuit (NASDAQ:INTU) stock fell 2.6% after the financial software company issued disappointing guidance for the second quarter and fiscal year.

  • Ross Stores (NASDAQ:ROST) stock rose 6.9% after the off-price retailer raised its annual profit forecast, as lower freight and supply-chain costs helped soften the impact of slowing sales.

  • Texas Pacific (NYSE:TPL) stock rose 5.1% with the energy company set to join the S&P 500 index next week, with current constituent Marathon Oil (NYSE:MRO) being acquired by ConocoPhillips (NYSE:COP).

  • Palo Alto Networks (NASDAQ:PANW) stock fell 0.7% after HSBC (LON:HSBA) downgraded its stance on the cybersecurity company to ‘reduce’ from ‘hold’ amid valuation concerns.

  • Reddit (NYSE:RDDT) stock fell 7.2% after Bloomberg reported that a shareholder of the social media company is seeking to establish a credit facility using an equity stake in the company.

  • MicroStrategy (NASDAQ:MSTR) stock added 1.3% and Coinbase (NASDAQ:COIN) gained 0.9%, with both companies supported by the rise in the cryptocurrencies, as bitcoin nears $100,000.

  • Nvidia (NASDAQ:NVDA) stock fell 0.6% after Phillip Securities downgraded its stance on the semiconductor manufacturer to ‘accumulate’ from ‘buy’, citing recent price action.

  • Honeywell (NASDAQ:HON) stock fell 0.2% after the conglomerate said it would sell its personal protective equipment business to Protective Industrial Products for about $1.33 billion in cash.

  • Replimune (NASDAQ:REPL) stock rose 15% after the biotechnology firm's announcement of significant regulatory progress for its lead cancer product.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.